Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |
| ES Clinical Research | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer.
It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
This is a non-interventional, observational, descriptive, cross-sectional clinical study with both prospective and retrospective data collection. It aims to describe the demographic, epidemiological, clinical, and outcome characteristics of approximately 1,000 patients with histologically confirmed gastric cancer in Algeria, and to analyze diagnostic and treatment practices.
Data will be collected from medical records and brief patient interviews (≈30 minutes). All information will be anonymized and used exclusively for research purposes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Demographic characteristics of patients with gastric cancer in Algeria | The patient's demographic profile will include age (years) and sex. Body Mass Index (BMI) will be calculated using weight (kg) and height (m) according to the formula BMI = weight / height² (kg/m²). | At Baseline ( Initial visit ) |
| Sociological characteristics of patients with gastric cancer in Algeria | The patient's sociological profile will be described as a composite variable : Education level (primary, secondary, university, other), Profession (employed, unemployed, retired, student, other), Place of residence (current residence; urban or rural), Origin (wilaya of birth/origin) | At Baseline ( Initial visit ) |
| Epidemiological characteristics of patients with gastric cancer in Algeria. | Frequency (%) of epidemiological risk factors including family history of cancer, Helicobacter pylori infection, smoking status, alcohol consumption, dietary habits, and exposure to chemical substances. | At Baseline (Initial Visit) |
| Clinical characteristics of patients with gastric cancer in Algeria. | Distribution of patients according to initial symptoms, tumor localization, histological characteristics, biomarker expression, presence of metastases, and tumor stage according to the AJCC classification. | At Basline ( Initial Visit) |
| Evolutionary characteristics of patients with gastric cancer. | Distribution of treatment modalities including surgery (palliative or curative) and chemotherapy (adjuvant or treatment lines), as well as treatment response, complications, disease-free survival (DFS), and duration of response. | At Baseline ( Initial Visit) |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic modalities in patients with gastric cancer in Algeria | Proportion (%) of patients diagnosed using endoscopy, biopsy, or imaging, and median time to diagnosis (days) defined as the interval between first reported symptom and confirmed diagnosis. | At Basline (Initial Visit) |
| Therapeutic management modalities |
Not provided
Inclusion Criteria:
Non Inclusion Criteria:
Not provided
Not provided
Not provided
Patients with histologically confirmed gastric cancer, followed in the participating oncology departments.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cac Blida | Not yet recruiting | Algiers | Algeria | 16000 | Algeria |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Proportion (%) of patients receiving surgery, chemotherapy, targeted therapy, immunotherapy, or palliative care, median time from confirmed diagnosis to initiation of first treatment (days), and proportion of patients with documented post-treatment follow-up. |
| At Baseline (Initial Visit) |
| CHU Béni Messous | Recruiting | Algiers | Algeria | 16000 | Algeria |
|
| CPMC | Not yet recruiting | Algiers | Algeria |
|
| EPH Rouiba | Not yet recruiting | Algiers | Algeria |
|
| CHU Annaba | Not yet recruiting | Annaba | Algeria |
|
| CHU Constantine | Not yet recruiting | Constantine | Algeria |
|
| EPH Constantine | Not yet recruiting | Constantine | Algeria |
|
| CAC Oued Souf | Not yet recruiting | El Oued | Algeria |
|
| CAC Oran | Not yet recruiting | Oran | Algeria |
|
| CHU Oran | Not yet recruiting | Oran | Algeria |
|
| EHU Oran | Not yet recruiting | Oran | Algeria |
|
| CAC Sétif | Not yet recruiting | Sétif | Algeria |
|
| CAC Sidi Bel Abbès | Not yet recruiting | Sidi Bel Abbes | Algeria |
|
| EPH Sidi Ghiles | Not yet recruiting | Tipasa | Algeria |
|
| CAC DBK | Not yet recruiting | Tizi Ouzou | Algeria |
|
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| D004194 | Disease |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided